FBLG Rasio cepet FibroBiologics

Backed by a powerful array of over 150 global patents, FibroBiologics, Inc. (FBLG) has created an insurmountable barrier for competitors, leveraging cutting-edge developments in molecular biology and tissue regeneration. This price chart illustrating trading dynamics reflects the company's assets, with a metric of 2.65. A unique approach to treating chronic pathologies via cellular platforms paves the way for establishing pricing power within the medical field.

Likuiditas cepet FibroBiologics (FBLG): kanggo periode 21.02.2024 - 29.10.2026

Ringkesan rincian data analitis FibroBiologics, Inc. (FBLG)

- rega saham lan prakiraan rega para ahli:

Rega saham fibrobiologics.com|FBLG - Target konsensus

- data kapitalisasi pasar:

Kapitalisasi pasar FibroBiologics Corp|FBLG - Total Nilai Perusahaan

- indikator nilai aset resik miturut neraca:

Aset Bersih saben Siji Saham FibroBiologics|FBLG - Nilai Buku Perusahaan|Rasio Nilai Pasar marang Nilai Buku fibrobiologics.com|FBLG - Aset Agregat Perusahaan

- data liabilitas lan likuiditas perusahaan:

Utang marang Ekuitas FibroBiologics, Inc.|FBLG - Rasio tanggungan utang jangka dawa marang modal|Utang jangka cendhak marang modal fibrobiologics.com|FBLG - Gunggung tanggungan utang perusahaan|Utang-utang marang kapitalisasi buku FibroBiologics Corp|FBLG - Gunggunge utang jangka dawa|Utang jangka cendhak perusahaan FibroBiologics|Likuiditas cepet fibrobiologics.com

- rincian bathi lan kelipatan pasar:

FBLG - Bathi pungkasan

Analisis umum perusahaan:FibroBiologics Inc. - FBLG

Produk asil prodhuksi FibroBiologics, Inc.

The high level of this metric confirms the financial stability of FibroBiologics, Inc. (FBLG), demonstrating the company's ability to settle short-term debts without liquidating inventory. By analyzing the cash ratio, an investor can see the volume of liquid assets required to maintain costly stem cell logistics and ensure the uninterrupted transport of biomaterials between research centers under strict security requirements.

Pesaing FibroBiologics, Inc. (FBLG)